Article | July 12, 2017

Biosimilars. Are They Ready for Primetime?

Source: Bio-Rad Laboratories, Inc.

By Gina Battaglia and Leala Thomas

Biorad

Is the hype surrounding biosimilars real or simply a hopeful view on an exceedingly expensive drug market? Substantial savings with these effective alternative treatments have been promised, but can they really deliver a viable alternative treatment?